Literature DB >> 12610114

Glial cell-specific regulation of the JC virus early promoter by histone deacetylase inhibitors.

So-Young Kim1, Moon-Sook Woo, Won-Ki Kim, Eung-Chil Choi, John W Henson, Hee-Sun Kim.   

Abstract

The human polyomavirus JC virus is the etiologic agent of the fatal disease demyelinating progressive multifocal leukoencephalopathy. Although multiple transcription factors have been shown to interact with the JC virus promoter and regulate transcriptional activity, their relevance to cell specificity remains elusive. To investigate whether chromatin structure controls glial cell-specific expression of JC virus early genes, glial and nonglial cells were transfected with a reporter plasmid containing the JC virus early promoter and then treated with the histone deacetylase (HDAC) inhibitors trichostatin A (TSA) and sodium butyrate. TSA and butyrate induced 20- to 30-fold activation of the JC virus promoter in nonglial cells, whereas less than 2-fold induction was observed in glial cells. These results indicate that the JC virus early promoter might be highly suppressed in nonglial cells by hypoacetylated chromatin and activated by hyperacetylation. In support of this, chromatin immunoprecipitation assays demonstrated acetylation of the JC virus promoter region in U87MG cells but no acetylation in HeLa cells. In addition, treatment of HeLa cells with TSA induced hyperacetylation of the JC virus promoter, whereas minimal induction was seen in U87MG cells. Deletional and site-directed mutational analyses revealed that the enhancer region and Sp1 binding site upstream of the TATA box were important for TSA-mediated activation. We confirmed TSA-mediated activation of the JC virus promoter in the context of natural chromatin structure in stable cell lines. Thus, it appears that chromatin structure may control JC virus transcription in a cell-specific manner.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12610114      PMCID: PMC149517          DOI: 10.1128/jvi.77.6.3394-3401.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Adjacent nuclear factor-1 and activator protein binding sites in the enhancer of the neurotropic JC virus. A common characteristic of many brain-specific genes.

Authors:  K Amemiya; R Traub; L Durham; E O Major
Journal:  J Biol Chem       Date:  1992-07-15       Impact factor: 5.157

2.  Cell-specific activation of the glial-specific JC virus early promoter by large T antigen.

Authors:  J W Henson; B L Schnitker; T S Lee; J McAllister
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

3.  Regulation of the glial-specific JC virus early promoter by the transcription factor Sp1.

Authors:  J W Henson
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

4.  Expression of recombinant plasmids in mammalian cells is enhanced by sodium butyrate.

Authors:  C M Gorman; B H Howard; R Reeves
Journal:  Nucleic Acids Res       Date:  1983-11-11       Impact factor: 16.971

5.  Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A.

Authors:  M Yoshida; M Kijima; M Akita; T Beppu
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

6.  A DNA cassette containing a trimerized SV40 polyadenylation signal which efficiently blocks spurious plasmid-initiated transcription.

Authors:  I H Maxwell; G S Harrison; W M Wood; F Maxwell
Journal:  Biotechniques       Date:  1989-03       Impact factor: 1.993

7.  The transcription factor Sp1 binds to the JC virus promoter and is selectively expressed in glial cells in human brain.

Authors:  J Henson; J Saffer; H Furneaux
Journal:  Ann Neurol       Date:  1992-07       Impact factor: 10.422

8.  Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992.

Authors:  H Bacellar; A Muñoz; E N Miller; B A Cohen; D Besley; O A Selnes; J T Becker; J C McArthur
Journal:  Neurology       Date:  1994-10       Impact factor: 9.910

Review 9.  Effects of sodium butyrate, a new pharmacological agent, on cells in culture.

Authors:  J Kruh
Journal:  Mol Cell Biochem       Date:  1982-02-05       Impact factor: 3.396

Review 10.  Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  E O Major; K Amemiya; C S Tornatore; S A Houff; J R Berger
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

View more
  6 in total

Review 1.  Persistence and pathogenesis of the neurotropic polyomavirus JC.

Authors:  Hassen S Wollebo; Martyn K White; Jennifer Gordon; Joseph R Berger; Kamel Khalili
Journal:  Ann Neurol       Date:  2015-03-06       Impact factor: 10.422

Review 2.  HDAC inhibitors and neurodegeneration: at the edge between protection and damage.

Authors:  Karen C Dietz; Patrizia Casaccia
Journal:  Pharmacol Res       Date:  2010-02-01       Impact factor: 7.658

Review 3.  The oncogenic roles of JC polyomavirus in cancer.

Authors:  Hua-Chuan Zheng; Hang Xue; Cong-Yu Zhang
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

4.  Fragile X (CGG)n repeats induce a transcriptional repression in cis upon a linked promoter: evidence for a chromatin mediated effect.

Authors:  Simon P Chandler; Pushpa Kansagra; Mark C Hirst
Journal:  BMC Mol Biol       Date:  2003-03-21       Impact factor: 2.946

5.  Epigenetic regulation of polyomavirus JC.

Authors:  Hassen S Wollebo; Baheru Woldemichaele; Kamel Khalili; Mahmut Safak; Martyn K White
Journal:  Virol J       Date:  2013-08-23       Impact factor: 4.099

Review 6.  Regulation of Polyomavirus Transcription by Viral and Cellular Factors.

Authors:  June F Yang; Jianxin You
Journal:  Viruses       Date:  2020-09-24       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.